Efficacy of a Novel Antibody TLR3 Modulator in the Self-Treatment of Common Cold: The ESTUAR Trial

ISSN Print: 2164-2648
ISSN Online: 2164-2656
www.scirp.net/journal/aid
E-mail: [email protected]

Citations

"Efficacy of a Novel Antibody TLR3 Modulator in the Self-Treatment of Common Cold: The ESTUAR Trial"
written by Andrey Martyushev-Poklad, Jacques Bruhwyler, Stéphane Heijmans, Michel Thiry,
published by Advances in Infectious Diseases, Vol.5 No.4, 2015

has been cited by the following article(s):

[1]	Delivery of Orally Administered Digestible Antibodies Using Nanoparticles
	2021

[2]	Isopathic Remedy Prepared from Convalescent Plasma as a Therapeutic Option for COVID-19?
	2020

[3]	Herbal medicines (Eunkyosan and Samsoeum) for treating the common cold: a protocol for a randomized, placebo-controlled, multicenter clinical trial
	2020

[4]	ПЕРСПЕКТИВЫ ИСПОЛЬЗОВАНИЯ АГОНИСТОВ И АНТАГОНИСТОВ Toll-ПОДОБНЫХ РЕЦЕПТОРОВ ДЛЯ ПРОФИЛАКТИКИ И ЛЕЧЕНИЯ ВИРУСНЫХ …
	2019

[5]	Перспективы использования агонистов и антагонистов Toll-подобных рецепторов для профилактики и лечения вирусных инфекций
	2019

[1]	Delivery of Orally Administered Digestible Antibodies Using Nanoparticles International Journal of Molecular Sciences, 2021 DOI:10.3390/ijms22073349

[2]	Herbal medicines (Eunkyosan and Samsoeum) for treating the common cold: a protocol for a randomized, placebo-controlled, multicenter clinical trial Integrative Medicine Research, 2020 DOI:10.1016/j.imr.2020.01.009

[3]	PROSPECTS OF Toll-LIKE RECEPTOR AGONISTS AND ANTAGONISTS FOR PREVENTION AND TREATMENT OF VIRAL INFECTIONS Medical Immunology (Russia), 2019 DOI:10.15789/1563-0625-2019-3-397-406